|4Dec 7, 7:03 PM ET

BOYER HERBERT W PH D 4

4 · ALLERGAN INC · Filed Dec 7, 2011

Insider Transaction Report

Form 4
Period: 2011-12-05
Transactions
  • Award

    Phantom Stock Units

    2011-12-01$84.18/sh+10.41$87617,530.87 total
    Common Stock (10.41 underlying)
  • Award

    Phantom Stock Units

    2011-12-06$84.17/sh+23.76$2,00017,590.47 total
    Common Stock (23.76 underlying)
  • Award

    Phantom Stock Units

    2011-12-05$83.72/sh+17.92$1,50017,548.79 total
    Common Stock (17.92 underlying)
  • Award

    Phantom Stock Units

    2011-12-05$83.72/sh+17.92$1,50017,566.71 total
    Common Stock (17.92 underlying)
Footnotes (4)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly dividend, exempt transaction under Rule 16a-11.
  • [F3]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F4]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. Director.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT